Cystobid POM to P consultation - nitrofurantoin
posted by John Blenkinsopp @ 15:34
2 comments
Blenkinsopp Pharma Consultancy
The weblog of Professor Alison Blenkinsopp and Dr John Blenkinsopp. Healthcare starts with self-care.
About Me
- Name: John Blenkinsopp
- Location: Leeds, United Kingdom
I work as a Senior Research Fellow in the Department of Medicines Management at Keele University. In addition, I run a consultancy business (Blenkinsopp Pharma Consultancy, http://www.blenkinsopp.co.uk ) which specialises in the reclassification of medicines to make them more easily accessible to the public. My work at Keele University involves working with IMPACT DETAILING, which provides an academic detailing capability (see http://www.impactdetailing.org.uk for more informaition). I am also involved in Creative Medicines Management (http://www.creamm.co.uk ) a spin-off business of the Department of Medicines Management. Finally, I am a Non-Executive Director of LUTO Research Ltd. (http://www.luto.co.uk )a company specialising in user testing of Patient Information Leaflets (PILs). In my spare time I paint and etch!
Previous Posts
- CHPA meeting 2009
- Naproxen switches for dysmenorrhoea
- Cystobid POM to P consultation - nitrofurantoin
- Xenical may switch back to POM in Oz
- The Big Five O
- Curanail - antifungal nail paint moves from POM to P
- Imigran Recovery - the first UK OTC triptan
- DUPHAT 2006 - Dubai
- LUTO Research Ltd - User testing experts
- Naproxen remains OTC in Germany
Archives
- September 2005
- October 2005
- November 2005
- January 2006
- February 2006
- March 2006
- May 2006
- July 2006
- January 2007
- March 2008
- April 2008
- May 2009
